BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6404003)

  • 1. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
    Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
    Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage disequilibrium between the HLA-B14 subdivisions and HLA-A, DR and properdin factor B alleles.
    Darke C
    Tissue Antigens; 1984 Jan; 23(1):68-71. PubMed ID: 6583877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B14.1 in linkage disequilibrium with HLA-DR7.
    Dewar PJ
    Tissue Antigens; 1983 Oct; 22(4):310-1. PubMed ID: 6417830
    [No Abstract]   [Full Text] [Related]  

  • 4. Further evidence for the partition of HLA-B14.
    Darke C
    Tissue Antigens; 1980 Jan; 15(1):25-30. PubMed ID: 12735329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens in 88 cases of rheumatic fever observed in Martinique.
    Monplaisir N; Valette I; Bach JF
    Tissue Antigens; 1986 Oct; 28(4):209-13. PubMed ID: 3492779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset form of congenital adrenal hyperplasia in the HLA-B14; DR1 haplotype is caused by a duplication in the 21-OH MHC gene region.
    Boehm BO; Rosak C; Kuehnl P; Schöffling K
    Horm Metab Res; 1986 Nov; 18(11):791-2. PubMed ID: 3491779
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.
    Speiser PW; New MI; White PC
    N Engl J Med; 1988 Jul; 319(1):19-23. PubMed ID: 3260007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4 allotyping distinguishes HLA-B14.1 and B14.2 subgroups.
    O'Neill GJ; Mueller-Eckhardt G; Prel L; Schendel DJ
    Immunogenetics; 1984; 19(4):335-41. PubMed ID: 6585348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis.
    Armstrong RD; Behn A; Myles A; Panayi GS; Welsh KI
    J Rheumatol; 1983 Aug; 10(4):659-61. PubMed ID: 6413689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
    Pollack MS; Chin-Louie J; Callaway C; Blanco MA; Slavin K; Sullivan K; O'Reilly RJ; Dupont B
    J Clin Immunol; 1983 Oct; 3(4):341-51. PubMed ID: 6197424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.
    Davis JE; Cook RG; Brown MF; Pollack MS; Van M; Rich RR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):851-7. PubMed ID: 3493566
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.
    Davis JE; Rich RR; Van M; Le HV; Pollack MS; Cook RG
    J Clin Invest; 1987 Oct; 80(4):998-1008. PubMed ID: 2443540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association between an HLA-DR antigen and thyroid carcinoma.
    Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
    Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B14 subtyping by semi-nested PCR-SSP and haplotype distribution in a Spanish population.
    Santos S; Balas A; Lillo R; Garcia-Sanchez F; Merino JL; Vicario JL
    Tissue Antigens; 1997 Dec; 50(6):671-4. PubMed ID: 9458126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinoma.
    Herait P; Tursz T; Guillard MY; Hanna K; Lipinski M; Micheau C; Sancho-Garnier H; Schwaab G; Cachin Y; Degos L
    Tissue Antigens; 1983 Nov; 22(5):335-41. PubMed ID: 6419386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA phenotype polymorphism in the Lebanese population.
    Mansour I; Klaymé S; Naman R; Loiselet J; Hallé L; Kaplan C
    Transfus Clin Biol; 1996; 3(5):289-95. PubMed ID: 8950804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-B44 subtypes associated with extended MHC haplotypes.
    Kruskall MS; Eynon EE; Awdeh Z; Alper CA; Yunis EJ
    Immunogenetics; 1987; 26(4-5):216-9. PubMed ID: 3653939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens in Asian Indians: HLA-D-DR relationships.
    Suciu-Foca N; Reed E; Khan R; Coburn C; Lewison A; Hassanali R; Rohowsky C; Susinno E; Reemtsma K
    Hum Immunol; 1981 Nov; 3(3):261-70. PubMed ID: 6946986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pvu II polymorphism in the primate homologue of the mouse B144 (LST-1). A novel marker gene within the tumor necrosis factor region.
    de Baey A; Holzinger I; Scholz S; Keller E; Weiss EH; Albert E
    Hum Immunol; 1995 Jan; 42(1):9-14. PubMed ID: 7751164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes.
    De la Concha EG; Fernandez-Arquero M; Gual L; Vigil P; Martinez A; Urcelay E; Ferreira A; Garcia-Rodriguez MC; Fontan G
    J Immunol; 2002 Oct; 169(8):4637-43. PubMed ID: 12370403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.